U.S. markets closed
  • S&P 500

    3,811.15
    -18.19 (-0.48%)
     
  • Dow 30

    30,932.37
    -469.64 (-1.50%)
     
  • Nasdaq

    13,192.35
    +72.92 (+0.56%)
     
  • Russell 2000

    2,201.05
    +0.88 (+0.04%)
     
  • Crude Oil

    61.66
    -1.87 (-2.94%)
     
  • Gold

    1,733.00
    -42.40 (-2.39%)
     
  • Silver

    26.70
    -0.98 (-3.56%)
     
  • EUR/USD

    1.2088
    -0.0099 (-0.81%)
     
  • 10-Yr Bond

    1.4600
    -0.0580 (-3.82%)
     
  • GBP/USD

    1.3922
    -0.0091 (-0.65%)
     
  • USD/JPY

    106.5500
    +0.3200 (+0.30%)
     
  • BTC-USD

    47,214.10
    -513.81 (-1.08%)
     
  • CMC Crypto 200

    912.88
    -20.25 (-2.17%)
     
  • FTSE 100

    6,483.43
    -168.53 (-2.53%)
     
  • Nikkei 225

    28,966.01
    -1,202.26 (-3.99%)
     

InMode to Present at Barclays Global Healthcare Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

YOKNEAM, Israel, March 2, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, announced today that Moshe Mizrahy, Chairman and Chief Executive Officer, will present at the Barclays Global Healthcare Conference at the Loews Miami Beach Hotel in Miami, Florida, on March 11 at 1:35 pm EST.

InMode Logo (PRNewsfoto/InMode)
InMode Logo (PRNewsfoto/InMode)

Mr. Mizrahy will be available for one-on-one meetings during the conference. To schedule a meeting please contact your Barclays salesperson or Miri Segal at msegal@ms-ir.com.

A live webcast of the presentation will be available to the public at: https://inmodemd.com/investors/. The webcast will be archived for 90 days following the live presentation.

About InMode

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio-frequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically-accepted minimally-invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.

Investor Relations Contact:
Miri Segal
MS-IR LLC
Phone: (917) 607-8654
Email: ir@inmodemd.com

Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/inmode-to-present-at-barclays-global-healthcare-conference-301014200.html

SOURCE InMode Ltd.